Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce Robinson

Showing results (61-70 of 167) with videos related to

Pageof 17
Sort By:
Expert Review of Anticancer Therapy|October 27, 2012
Regional approaches to the management of patients with advanced, radioactive iodine-refractory differentiated thyroid carcinomaMarcia S Brose, Johannes Smit, Jaume Capdevila, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 21, 2012
Longer dialysis session length is associated with better intermediate outcomes and survival among patients on in-center three times per week hemodialysis: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS)Francesca Tentori, Jinyao Zhang, Yun Li, et al.
ESC Heart Failure|January 13, 2022
Routinely measured cardiac troponin I and N-terminal pro-B-type natriuretic peptide as predictors of mortality in haemodialysis patientsMasahiro Eriguchi, Kazuhiko Tsuruya, Marcelo Lopes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 26, 2020
Efficacy and Safety of Vandetanib in Progressive and Symptomatic Medullary Thyroid Cancer: Post Hoc Analysis From the ZETA TrialMichael C Kreissl, Lars Bastholt, Rossella Elisei, et al.
BMC Nephrology|January 4, 2022
Thrombocytopenia predicts mortality in Chinese hemodialysis patients- an analysis of the China DOPPSXinju Zhao, Qingyu Niu, Liangying Gan, et al.
Kidney360|January 26, 2023
Gout Prevalence, Practice Patterns, and Associations with Outcomes in North American Dialysis PatientsMurilo Guedes, Junhui Zhao, Brian LaMoreaux, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 6, 2019
Surgeon Characteristics and Dialysis Vascular Access Outcomes in the United States: A Retrospective Cohort StudyVahakn B Shahinian, Xiaosong Zhang, Anca M Tilea, et al.
Annals of Family Medicine|September 14, 2011
Nonsteroidal anti-inflammatory drug use among persons with chronic kidney disease in the United StatesLaura Plantinga, Vanessa Grubbs, Urmimala Sarkar, et al.
European Journal of Cancer (Oxford, England : 1990)|January 4, 2011
miR-124a is frequently down-regulated in glioblastoma and is involved in migration and invasionAdam Fowler, Daniel Thomson, Keith Giles, et al.
Clinical Journal of the American Society of Nephrology : CJASN|May 20, 2017
Examining the Association between Hemodialysis Access Type and Mortality: The Role of Access ComplicationsPietro Ravani, Robert Quinn, Matthew Oliver, et al.
Pageof 17

Showing results (61-70 of 167) with videos related to

Sort By:
Pageof 17
Expert Review of Anticancer Therapy|October 27, 2012
Regional approaches to the management of patients with advanced, radioactive iodine-refractory differentiated thyroid carcinomaMarcia S Brose, Johannes Smit, Jaume Capdevila, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 21, 2012
Longer dialysis session length is associated with better intermediate outcomes and survival among patients on in-center three times per week hemodialysis: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS)Francesca Tentori, Jinyao Zhang, Yun Li, et al.
ESC Heart Failure|January 13, 2022
Routinely measured cardiac troponin I and N-terminal pro-B-type natriuretic peptide as predictors of mortality in haemodialysis patientsMasahiro Eriguchi, Kazuhiko Tsuruya, Marcelo Lopes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 26, 2020
Efficacy and Safety of Vandetanib in Progressive and Symptomatic Medullary Thyroid Cancer: Post Hoc Analysis From the ZETA TrialMichael C Kreissl, Lars Bastholt, Rossella Elisei, et al.
BMC Nephrology|January 4, 2022
Thrombocytopenia predicts mortality in Chinese hemodialysis patients- an analysis of the China DOPPSXinju Zhao, Qingyu Niu, Liangying Gan, et al.
Kidney360|January 26, 2023
Gout Prevalence, Practice Patterns, and Associations with Outcomes in North American Dialysis PatientsMurilo Guedes, Junhui Zhao, Brian LaMoreaux, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 6, 2019
Surgeon Characteristics and Dialysis Vascular Access Outcomes in the United States: A Retrospective Cohort StudyVahakn B Shahinian, Xiaosong Zhang, Anca M Tilea, et al.
Annals of Family Medicine|September 14, 2011
Nonsteroidal anti-inflammatory drug use among persons with chronic kidney disease in the United StatesLaura Plantinga, Vanessa Grubbs, Urmimala Sarkar, et al.
European Journal of Cancer (Oxford, England : 1990)|January 4, 2011
miR-124a is frequently down-regulated in glioblastoma and is involved in migration and invasionAdam Fowler, Daniel Thomson, Keith Giles, et al.
Clinical Journal of the American Society of Nephrology : CJASN|May 20, 2017
Examining the Association between Hemodialysis Access Type and Mortality: The Role of Access ComplicationsPietro Ravani, Robert Quinn, Matthew Oliver, et al.
Pageof 17